Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-06-2020 | Letter to the Editor

Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT

Authors: Paulo Schiavom Duarte, Marcelo Tatit Sapienza

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2020

Excerpt

Dear Sir, …

van der Bruggen W, Hagelstein-Rotman M, de Geus-Oei L-F, Smit F, Dijkstra PDS, Appelman-Dijkstra NM, et al. Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT. Eur J Nucl Med Mol Imaging. 2019. https://doi.org/10.1007/s00259-019-04657-1.

Collins MT, Kushner H, Reynolds JC, Chebli C, Kelly MH, Gupta A, et al. An instrument to measure skeletal burden and predict functional outcome in fibrous dysplasia of bone. J Bone Miner Res. 2004;20:219–26.CrossRef

Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, et al. Determination of skeletal tumor burden on 18F-fluoride PET/CT. J Nucl Med. 2015;56:1507–12.CrossRef

Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrne NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44:1051–65.CrossRef

Marin JFG, Duarte PS, de Amorim de Carvalho JW, Sado HN, Sapienza MT, Buchpiguel CA. Comparison of the variability of SUV normalized by skeletal volume with the variability of SUV normalized by body weight in 18F-fluoride PET/CT. J Nucl Med Technol. 2019;47:60–3.CrossRef

Carvalho G, Marin JFG, Garcez AT, Duarte PS, Sapienza MT, Buchpiguel CA. SUV normalized by skeletal volume on 18F-fluoride PET/CT studies. Clin Nucl Med. 2016;41:529–33.CrossRef

Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17–31.CrossRef

Boellaard R. Standards for PET image acquisition and quantitative data analysis. J Nucl Med. 2009;50(Suppl 1):11S–20S.CrossRef

Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847–50.CrossRef

10.

Tahari AK, Chien D, Azadi JR, Wahl RL. Optimum lean body formulation for correction of standardized uptake value in PET imaging. J Nucl Med. 2014;55:1481–4.CrossRef

11.

Gafita A, Calais J, Franz C, Rauscher I, Wang H, Roberstson A, et al. Evaluation of SUV normalized by lean body mass (SUL) in Ga-PSMA11 PET/CT: a bi-centric analysis. EJNMMI Res. 2019;9:103.CrossRef

12.

Blau M, Ganatra R, Bender MA. 18F-fluoride for bone imaging. Semin Nucl Med. 1972;2:31–7.CrossRef

13.

Kurdziel KA, Shih JH, Apolo AB, Lindenberg L, Mena E, McKinney YY, et al. The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology. J Nucl Med. 2012;53:1175–84.CrossRef

Title: Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT
Authors: Paulo Schiavom Duarte
Marcelo Tatit Sapienza
Publication date: 01-06-2020
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2020
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-020-04688-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Normalization by bone volume instead of body weight or lean body mass may be better for quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2020

Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS

FDG-PET/CT in the detection of pituitary stalk ACTH-secreting adenoma

Individualized discrimination of tumor recurrence from radiation necrosis in glioma patients using an integrated radiomics-based model

Integration of PET-imaging into radiotherapy treatment planning for low-grade meningiomas improves outcome

Realising the potential of radioligand therapy: policy solutions for the barriers to implementation across Europe

Prediction of survival in patients with IDH-wildtype astrocytic gliomas using dynamic O-(2-[18F]-fluoroethyl)-l-tyrosine PET